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Sickle Cell Anemia
Esther Bassaw RN, BSN
Otterbein University, Westerville, Ohio
Introducation
Sickle Cell Anemia (SCA) is a group of
inherited red blood cell (RBC) disorders
caused by a single mutation on the β-globin
gene which causes the synthesis of an
abnormal hemoglobin S (HbS) (Connes et al.,
20118). A healthy red blood cell has a round
shape that allows it to easily move through
small blood vessels to carry oxygen to supply
to all parts of the body (CDC, 2017). In SCA
individuals, the sickle cell assumes a C-shape
called “sickle” (CDC, 2017). This sickle shape
gets them to stuck and clog the blood flow
when moving through the small blood vessels,
this lead to the typical symptoms of pain and
infection, and complication such as chest
syndrome and stoke (CDC, 2017).
African countries carry the highest
incident of individuals with the SCA (Centers
for Disease Control and Prevention (CDC),
2017). In the United State, approximately 1 in
12 African-Americans carry the trait for SCA,
and 1 of every 350 African-American infants
born have the disorder (CDC, 2017). However,
the disease is also familiar with Hispanics,
Indians, and individuals with Asian
backgrounds (CDC, 2017).

Underlying Pathophysiology

Pathophysiological Process
➢

➢

➢

➢

SCA is a genetic disorder inherited from a mother, father, or both parents that are present
from birth. SCA is as a result of a single mutation on a hemoglobin-beta gene which causes
the synthesis of an abnormal hemoglobin S (HbS) (Connes et al., 20118). Hemoglobin (Hb) is
a molecule in RBC responsible for the transportation of oxygen hence during deoxygenation,
HbS polymerizes and causes sickle cell deformity which also initiates a pathological cascade
that results in injury to the red sickle cell, hemolysis, and vaso-occlusion of RBC (Connes et
al., 2018).
The sickle-shaped RBC causes a blockage that slows or stops the flow of blood(Connes et al.,
2018). When this happens, oxygen cannot reach targeted tissues. Deoxygenation can cause
attacks of sudden and severe pain called “pain crises” (Connes et al., 2018) Due to the
deformed shape, cells can also stick to vessel walls, and HbS induces RBC membrane damage
leading to an imbalance of calcium, potassium, and water exchange into and out of the cell
(Waltz & Connes, 2014). Accumulation of Calcium within the cell allows for the efflux of
potassium and water from the cell, which leads to dehydration and Vaso-occlusive crisis
(Waltz & Connes, 2014). The vasso-occlusion causes an obstruction and reduce blood flow to
the vital organs leading to ischemia, necrosis, and pain. Repeated episodes of deoxygenation
and oxygenation weaken the RBC cell membranes (Smith, 2014). The average life span of a
healthy RBC is 90 to 120 days. However, weakened RBCs are hemolyzed and removed within
10 to 20 days resulting in increased demand for RBC production that produces the
symptoms of feeling fatigued and lethargy (Waltz & Connes, 2014).
SCA has an autosomal recessive inheritance pattern, which means an individual must inherit
two copies of a recessive allele from both parents in order to have the condition: individuals
that carry one dominant and one recessive allele are carriers (CDC, 2017). Sickle cell carriers
usually live a healthy life and do not exhibit any of the signs of the disease; however, they can
pass the trait on to their offspring (CDC, 2017).
The risk for septicemia and meningitis is prevalent in about 10% of children with SCA during
the first three years of life; bacterial infections are the most common cause of death at any
age (Matthie & Jenerette, 2015). The swelling and inflammation of the hands and other
infections are caused by poor blood circulation due to blocked vessels (Matthie & Jenerette,
2015). Severe abdominal pain is caused by splenic sequestration that’s blood pooling within
the spleen, which causes the spleen to become enlarged (splenomegaly) (Matthie & Jenerette,
2015). Breathing complications (chest syndrome) results from lack of oxygen being
transported from the lungs to other areas of the body and retention of carbon dioxide (Smith,
2014). Deoxygenation and high levels of carbon dioxide also cause other complications of the
heart, brain, and muscles as these organs rely on oxygen for homeostasis (Smith, 2014).
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Every healthy adult hemoglobins consist of two alpha chains with
141 amino acids in sequence complemented non-alpha chains of
beta, gamma or delta (Bellas, 2018). The non-alpha chain instead
composes of 146 amino acids in the sequence (Bellas, 2018).
Sickling of RBC happens when a healthy alpha chain of amino
acid of Hemoglobin is substituted with the beta chain (Bellas,
2018). This result in the abnormal synthesis of one of the amino
acid chains on chromosome 11(Bellas, 2018).
Every beta-globin chain has a sequenced group of amino acids
indicating glutamine in the sixth position from the terminal end
(Bellas, 2018). In SCA, the abnormal beta-globin chain is a result
of a substitution of glutamine amino acid by valine indicated on
the sixth position of the beta chain which results in abnormal
HbS present in the person’s red blood cells (Bellas, 2018).
The inheritance of a single abnormal amino acid makes an
individual a carrier with sickle cell trait which means that the
person inherits one copy of alpha (α) chains (HBA) and one copy
of beta (β) chains (HbS) (Bellas, 2018). Receiving two copies of
mutated two beta (β) chains (HbS) inheritance results in sickle
cell disease (SCD) with severe signs and symptoms that alter the
person’s quality of life and life span (Bellas, 2018).

Significance of Pathophysiology

SCA is a public concern. The cost of
hospital stay during crisis and management of
complication of SCA was estimated at $488
billion (CDC, 2017). With early and effective
interventions, there could be a decrease in
hospitalizations for cost-effectiveness and also
increase life expectancy and overall quality of
care delivered to individuals in this population.
Understanding the pathophysiology underlining
SCA will enable health care providers to
effectively manage symptoms, prevent
complication and treat pain to improve quality
of life in this patients population.

Signs and Symptoms
During crisis, signs and symptoms may
include
❖
❖
❖
❖
❖
❖
❖
❖

Pallor
Pain crisis
Fatigue
Lethargy
Anemia
Jaundice
irritability
swelling of hands, feet and joints.
(Matthie, & Jenerette, 2015).

Complication

The most serious, acute complications of SCA
include:
❖
cardiovascular collapse due to acute
sequestration crisis
❖
cerebrovascular accident
❖
acute respiratory distress syndrome due to
acute chest syndrome
❖
aplastic crisis that progresses to highoutput heart failure
❖
pneumonia and infections that progress to
septicemia
The most serious, chronic complications of SCA
include organ failure of the heart, liver, and kidney
and loss of vision that may lead to complete
blindness.

Knowing the pathophysiology
of the disease, the nurse will treat
pain with analgesics and hydration
promptly. The nurse educates and
advocate for the patients and
family about their treatment
options The nurse ensures that
patients stay current on their
childhood vaccinations,
pneumococcal vaccine, and the
annual flu shot for prevention of
infection and other complications
(Onimoe & Smarzo, 2017). The
nurse will educate patients about
pain medication tolerance, how to
manage stress and explore other
pain relief techniques such as heat,
therapy, acupuncture, and when to
contact the healthcare provider
(Onimoe & Smarzo, 2017). The
nurse will provide resources for
community support groups and
organizations that will help
patients with other specialty
coping mechanisms

Conclusion

❑

Topic Statement

Implication for Nursing Care
Nurses play a significant role in the
management of signs and symptoms and
treatment of individuals with SCA. Since
treatment is aimed at relieving of
symptoms and prevention of
complication educating patients on
taking their prescribed medications such
as antibiotics, vitamins, and other painrelieving medicines to prevent a crisis is
essential (Smith, 2014). Nurses ensure
to teach patients effective measures to
prevent crisis such as drinking more
fluids, staying warm, avoiding large
crowds, avoiding smoking, and secondhand smoking (Matthie & Jenerette,
2015). The nurse teaches the parents to
understand effective measures to
control pain. For the teen and adult, the
nurse educates patients to choose safe
physical activities that can improve pain
management yet reduce stress on the
joint to avoid further complications
(Waltz & Connes, 2014). During a crisis,
nurses ensure to prevent infection, and
carefully assess patients for early signs
of complications that indicate damage to
any organ, and promptly report critical
labs and negative diagnostic test for
specific treatment including possible
surgery and blood transfusions (Matthie
& Jenerette, 2015).

❑
❑
❑

❑

Understanding the etiology and the pathophysiology
underlining the SCA will enable health care providers to
effectively manage symptoms and treat pain to improve the
quality of life in this patients population.
Primary prevention involves genetic counseling and general
public knowledge about the pathophysiological process of the
disease.
Early detection through embryonic and newborn screening is
necessary to reduce morbidity.
Management of SCD is mainly prevention of complications and
aggressive treatment of hydration during a crisis as well as
pain management. For children, prophylactic antibiotics and
pneumococcal vaccines are encouraged as well as stroke
prevention techniques.
that bone marrow transplant is the only evidenced base cure
for sickle cell anemia and other experimental trails such as
gene therapy, nitric oxide, and drugs that helps to boost
hemoglobin production and reduce viscosity such as GMI 1070
are underway (Wun et al., 2014).

SCA is an inherited blood disorder where
RBC takes an abnormal C-shape which impedes
blood flow in vessels (Onimoe & Smarzo, 2017).
This obstruction of blood blow causes Vassoocclusion that result in acute illness and
progressive multiple organ damage. Pain
“crisis” is the hallmark symptoms of SCA
(Onimoe & Smarzo, 2017). SCA is caused by a
mutation in the hemoglobin beta gene situated
on chromosome 11 (Bellas, 2018). SCA is a
recessive genetic disorder where two copies of
mutated genes have to be inherited from both
parents for one to portray the symptoms
(Bellas, 2018). Individuals who inherit a copy
of the mutated gene are referred to be the sickle
cell trait carrier who may live symptoms free in
their lifespan (Bellas, 2018).The average life
expectancy for this population has increased as
a result of improved management of symptoms
and bone marrow replacement (Gardner,
2018). Health care providers ensure to educate
patients on the importance of following
medication regime to reduce aggregation of
symptoms to prevent complication (Waltz &
Connes, 2014). Both family and patient
education are essential to reduce prevalence
and complication of SCA.
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